Full history for every metric is available with a Kvantra account

Stock profile

Brighten Optix Corporation (6747.TWO)

Country: TaiwanSector: HealthcareIndustry: Medical - DevicesExchange: TWO

Delisted · last close 5 Dec 2025

Current price
199.00 TWD0.00%
Last close 5 Dec 2025
Benchmarks

Key financial summary

Financials in TWD
201920202021202220232024TTM
Total revenueTWD m488541645744747767767
Operating profitTWD m157118
Net profitTWD m11512524125619915068
EPS reportedTWD5.492.52
Operating cashflow per shareTWD6.873.66
Capex per shareTWD0.741.06
FCF per shareTWD6.132.61
Free cash flowTWD m167178
Net debtTWD m-670-461
Book value equityTWD m1,4111,155
Book value per shareTWD51.7143.34
Number of sharesm27.2926.66
DPS (TTM paid)TWD13.979.19

Financial summary

Financials in TWD
201920202021202220232024TTM
Value
P/E TTMx24.2378.97
P/B LTMx2.564.68
P/S LTMx4.727.06
P/FCF LTMx21.6930.47
EV/EBITDA LTMx10.9932.67
EV/Sales LTMx3.906.46
Earnings Yield LTM%4.13%1.27%
FCF Yield%4.61%3.28%
Quality
ROE%10.61%3.99%
ROIC%8.92%7.17%
Operating margin%20.47%14.94%
Gross margin%65.66%64.32%
FCF/Sales%21.75%11.84%
Growth and momentum
EPS Growth YoY%-33.13%-55.40%
Sales Growth YoY%+2.63%+2.80%
Net Income Growth YoY%-24.82%-54.72%
FCF Growth%+4.69%+14.46%
Operating Profit Growth%-24.53%-28.70%
Dividend and capital structure
Dividend Yield%3.59%4.62%
Dividend Growth%--
Payout Ratio%86.79%365.68%
FCF/Debtx5.723.45
Net Debt/EBITDAx-2.30-3.60
EBIT/Net interestx164.90154.54
Net debt/market cap%-18.51%-8.51%
Net debt/Equityx-0.47-0.40
Gross debt/equityx0.020.04

Company overview

Brighten Optix Corporation focuses on the research, development, production, and sale of specialized contact lenses throughout Taiwan and the broader Asia Pacific market. The company's diverse product range includes hard contact lenses offered under the HiClear and Soclear brands, as well as soft contact lenses known as Brio+moist, iDealsoft, and MyOKvision. Additionally, Brighten Optix supplies lens care solutions, such as Oxy vision plus Briomoist and Mu likang, alongside various ancillary products and specific orthokeratology hard lenses designed for overnight wear. The corporation is headquartered in Taipei, Taiwan.

WebsiteN/A
IndustryMedical - Devices
CountryTaiwan
Trades inTWD

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Delisted · last close 5 Dec 2025

Brighten Optix Corporation (6747.TWO)

6747.TWO · TWO · Healthcare
199.00 TWD0.00%
Benchmarks
Financialsin TWD
20232024TTM
About

Brighten Optix Corporation focuses on the research, development, production, and sale of specialized contact lenses throughout Taiwan and the broader Asia Pacific market. The company's diverse product range includes hard contact lenses offered under the HiClear and Soclear brands, as well as soft contact lenses known as Brio+moist, iDealsoft, and MyOKvision. Additionally, Brighten Optix supplies lens care solutions, such as Oxy vision plus Briomoist and Mu likang, alongside various ancillary products and specific orthokeratology hard lenses designed for overnight wear. The corporation is headquartered in Taipei, Taiwan.

IndustryMedical - Devices
CountryTaiwan
Trades inTWD

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free